Previous Article | Next Article ![]()
Infect. Immun., May 1995, 1855-1862, Vol 63, No. 5
BU von Specht, B Knapp, G Muth, M Broker, KD Hungerer, KD Diehl, K Massarrat, A Seemann and H Domdey
Recombinant outer membrane proteins (Oprs) of Pseudomonas aeruginosa were
expressed in Escherichia coli as glutathione S-transferase (GST)- linked
fusion proteins. GST-linked Oprs F and I (GST-OprF190-350 [GST linked to
OprF spanning amino acids 190 to 350] and GST-OprI21-83, respectively) and
recombinant hybrid Oprs (GST-OprF190-342-OprI21-83 and
GST-OprI21-83-OprF190-350) were isolated and tested for their efficacy as
vaccines in immunodeficient mice. GST-OprF-OprI protected the mice against
a 975-fold 50% lethal dose of P. aeruginosa. Expression of GST-unfused
OprF-OprI failed in E. coli, although this hybrid protein has been
expressed without a fusion part in Saccharomyces cerevisiae and used for
immunizing rabbits. The immune rabbit sera protected severe combined
deficient (SCID) mice against a 1,000-fold 50% lethal dose of P.
aeruginosa. Evidence is provided to show that the most C-terminal part of
OprF (i.e., amino acids 332 to 350) carries an important protective
epitope. Opr-based hybrid proteins may have implications for a clinical
vaccine against P. aeruginosa.
Copyright © 1995, American Society for Microbiology
Protection of immunocompromised mice against lethal infection with Pseudomonas aeruginosa by active or passive immunization with recombinant P. aeruginosa outer membrane protein F and outer membrane protein I fusion proteins
Chirurgische Universitatsklinik, Chirurgische Forschung, Freiburg, Germany.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|